Literature DB >> 33805785

Mg,Si-Co-Substituted Hydroxyapatite/Alginate Composite Beads Loaded with Raloxifene for Potential Use in Bone Tissue Regeneration.

Katarzyna Szurkowska1, Paulina Kazimierczak2, Joanna Kolmas1.   

Abstract

Osteoporosis is a worldwide chronic disease characterized by increasing bone fragility and fracture likelihood. In the treatment of bone defects, materials based on calcium phosphates (CaPs) are used due to their high resemblance to bone mineral, their non-toxicity, and their affinity to ionic modifications and increasing osteogenic properties. Moreover, CaPs, especially hydroxyapatite (HA), can be successfully used as a vehicle for local drug delivery. Therefore, the aim of this work was to fabricate hydroxyapatite-based composite beads for potential use as local carriers for raloxifene. HA powder, modified with magnesium and silicon ions (Mg,Si-HA) (both of which play beneficial roles in bone formation), was used to prepare composite beads. As an organic matrix, sodium alginate with chondroitin sulphate and/or keratin was applied. Cross-linking of beads containing raloxifene hydrochloride (RAL) was carried out with Mg ions in order to additionally increase the concentration of this element on the material surface. The morphology and porosity of three different types of beads obtained in this work were characterized by scanning electron microscopy (SEM) and mercury intrusion porosimetry, respectively. The Mg and Si released from the Mg,Si-HA powder and from the beads were measured by inductively coupled plasma optical emission spectrometry (ICP-OES). In vitro RAL release profiles were investigated for 12 weeks and studied using UV/Vis spectroscopy. The beads were also subjected to in vitro biological tests on osteoblast and osteosarcoma cell lines. All the obtained beads revealed a spherical shape with a rough, porous surface. The beads based on chondroitin sulphate and keratin (CS/KER-RAL) with the lowest porosity resulted in the highest resistance to crushing. Results revealed that these beads possessed the most sustained drug release and no burst release effect. Based on the results, it was possible to select the optimal bead composition, consisting of a mixture of chondroitin sulphate and keratin.

Entities:  

Keywords:  composite biomaterials; drug delivery system; magnesium ions; nanocrystalline hydroxyapatite; raloxifene; silicate ions

Mesh:

Substances:

Year:  2021        PMID: 33805785      PMCID: PMC7999305          DOI: 10.3390/ijms22062933

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  44 in total

1.  Comparative effects of raloxifene, tamoxifen and estradiol on human osteoblasts in vitro: estrogen receptor dependent or independent pathways of raloxifene.

Authors:  Yasuhiro Miki; Takashi Suzuki; Shuji Nagasaki; Shuko Hata; Jun-ichi Akahira; Hironobu Sasano
Journal:  J Steroid Biochem Mol Biol       Date:  2009-02-07       Impact factor: 4.292

2.  Ion reactivity of calcium-deficient hydroxyapatite in standard cell culture media.

Authors:  J Gustavsson; M P Ginebra; E Engel; J Planell
Journal:  Acta Biomater       Date:  2011-07-23       Impact factor: 8.947

3.  Raloxifene therapy interacts with serum osteoprotegerin in postmenopausal women.

Authors:  Enrico M Messalli; Giampaolo Mainini; Cono Scaffa; Angela Cafiero; Pier Luigi Salzillo; Angelo Ragucci; Luigi Cobellis
Journal:  Maturitas       Date:  2006-06-19       Impact factor: 4.342

4.  Solid state interaction of raloxifene HCl with different hydrophilic carriers during co-grinding and its effect on dissolution rate.

Authors:  Anuj Garg; S Singh; V U Rao; K Bindu; J Balasubramaniam
Journal:  Drug Dev Ind Pharm       Date:  2009-04       Impact factor: 3.225

5.  Preparation and evaluation of raloxifene-loaded solid dispersion nanoparticle by spray-drying technique without an organic solvent.

Authors:  Tuan Hiep Tran; Bijay K Poudel; Nirmal Marasini; Sang-Cheol Chi; Han-Gon Choi; Chul Soon Yong; Jong Oh Kim
Journal:  Int J Pharm       Date:  2013-01-11       Impact factor: 5.875

6.  Biomimetic Mg-substituted hydroxyapatite: from synthesis to in vivo behaviour.

Authors:  Elena Landi; Giandomenico Logroscino; Luca Proietti; Anna Tampieri; Monica Sandri; Simone Sprio
Journal:  J Mater Sci Mater Med       Date:  2007-06-28       Impact factor: 3.896

Review 7.  Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration.

Authors:  Wenyi Gu; Chengtie Wu; Jiezhong Chen; Yin Xiao
Journal:  Int J Nanomedicine       Date:  2013-06-25

Review 8.  Bone substitutes in orthopaedic surgery: from basic science to clinical practice.

Authors:  V Campana; G Milano; E Pagano; M Barba; C Cicione; G Salonna; W Lattanzi; G Logroscino
Journal:  J Mater Sci Mater Med       Date:  2014-05-28       Impact factor: 3.896

9.  Raloxifene: mechanism of action, effects on bone tissue, and applicability in clinical traumatology practice.

Authors:  Jose R Caeiro Rey; Eduardo Vaquero Cervino; Maria Luz Rentero; Emilio Calvo Crespo; Angel Oteo Alvaro; Marta Casillas
Journal:  Open Orthop J       Date:  2009-02-20

10.  Controlled release of raloxifene by nanoencapsulation: effect on in vitro antiproliferative activity of human breast cancer cells.

Authors:  Márcia Camponogara Fontana; Aline Beckenkamp; Andréia Buffon; Ruy Carlos Ruver Beck
Journal:  Int J Nanomedicine       Date:  2014-06-17
View more
  2 in total

1.  Multifunctional Nanomaterials: Synthesis, Properties and Applications.

Authors:  Raghvendra Singh Yadav
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923

Review 2.  Recent Reports on Polysaccharide-Based Materials for Drug Delivery.

Authors:  Joanna Kurczewska
Journal:  Polymers (Basel)       Date:  2022-10-06       Impact factor: 4.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.